Search
01/04/2022
Impact of the CHA2DS2-VASc score on late clinical outcomes in patients undergoing left atrial appendage occlusion (vol 319, pg 78, 2020)
Agudelo, V, Millan, X, Li, CH, Asmarats, L, Fernandez-Peregrina, E, Santalo, M, Jimenez-Kockar, M, Gheorghe, L, Serra, A, Arzamendi, D. Impact of the CHA2DS2-VASc score on late clinical outcomes in patients undergoing left atrial appendage occlusion (vol 319, pg 78, 2020). INTERNATIONAL JOURNAL OF CARDIOLOGY. 2022; 352DOI:10.1016/j.ijcard.2022.01.051. PMID:35177250. IF:3.500(Q2/5D).
01/04/2022
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome
Aulinas, A, Stantonyonge, N, Garcia-Patterson, A, Adelantado, JM, Medina, C, Espinos, JJ, Lopez, E, Webb, SM, Corcoy, R. Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome. Pituitary. 2022; 25(2)DOI:10.1007/s11102-021-01196-7. PMID:34846622. IF:3.800(Q2/5D).
01/04/2022
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic hematopoietic stem cell transplantation in Philadelphia acute lymphoblastic leukemia
Galán Gómez V., de la Fuente Regaño L., Rodríguez Villa A., Díaz de Heredia Rubio C., González Vicent M., Badell Serra I., Fernández J.M., Pascual Martínez A.I., Pérez Hurtado J.M., López Duarte M., Maldonado Regalado M.S., Pérez-Martínez A.. Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic hematopoietic stem cell transplantation in Philadelphia acute lymphoblastic leukemia. ANALES DE PEDIATRIA. 2022; 96(4)DOI:10.1016/j.anpedi.2021.02.015. PMID:33781716. IF:2.100(Q3/6D).
01/04/2022
Immune effector cell-associated neurotoxicity syndrome: A therapeutic approach in the critically ill
Montero, JCS, Gonzalez, ACC, Aguilar, LM, Cortes, JM. Immune effector cell-associated neurotoxicity syndrome: A therapeutic approach in the critically ill. Medicina Intensiva. 2022; 46(4)DOI:10.1016/j.medin.2020.06.014. PMID:32873409. IF:3.000(Q3/7D).
01/04/2022
Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas
Serda, PC, Teres, R, Sebio, A, Bague, S, Orellana, R, Moreno, ME, Riba, M, Lopez-Pousa, A. Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas. ADVANCES IN THERAPY. 2022; 39(4)DOI:10.1007/s12325-022-02051-2. PMID:35129790. IF:3.800(Q2/4D).
01/04/2022
Risk factors associated with emergency service re-visits in frailty diabetic patients who consult for hypoglycaemia
Mas Malagarriga N., Ruiz Ramos J., Juanes Borrego A.M., Agra Montava I., Vega Hanna L., López Vinardell L., Puig Campmany M., Mangues Bafalluy M.A.. Risk factors associated with emergency service re-visits in frailty diabetic patients who consult for hypoglycaemia. Medicina De Familia-Semergen. 2022; 48(3)DOI:10.1016/j.semerg.2021.09.011. PMID:34848135. IF:(Q/D).